MEDIOS AG Aktie · DE000A1MMCC8 · A1MMCC (XFRA) — Echtzeitkurse, Unternehmensdaten, Dividenden, Fundamentaldaten und KI-gestützte Portfolio-Analyse auf MoneyPeak

Medios AG, together with its subsidiaries, engages in the wholesale of specialty pharmaceutical drugs in Germany. It operates through Pharmaceutical Supply and Patient-Specific Therapies segments. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies; and patient-specific therapies for dispensing individually dosed tablets. The company was founded in 2016 and is based in Berlin, Germany.